このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Organon 将来の成長
Future 基準チェック /26
Organon利益と収益がそれぞれ年間7.2%と0.2%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に97.7% 6.8%なると予測されています。
主要情報
7.2%
収益成長率
6.8%
EPS成長率
| Pharmaceuticals 収益成長 | 23.7% |
| 収益成長率 | 0.2% |
| 将来の株主資本利益率 | 97.7% |
| アナリストカバレッジ | Good |
| 最終更新日 | 18 Sep 2024 |
今後の成長に関する最新情報
Recent updates
Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis
Sep 19These 4 Measures Indicate That Organon (NYSE:OGN) Is Using Debt In A Risky Way
Sep 13
Organon & Co.: Cheap With Caveats
Aug 22Organon (NYSE:OGN) Will Pay A Dividend Of $0.28
Aug 09Insufficient Growth At Organon & Co. (NYSE:OGN) Hampers Share Price
Aug 07Organon: Upcoming Q2 Earnings Can Sustain Upward Momentum
Jul 30Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year
May 29Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals
May 10Four Reasons Why Organon Stock Is A Good Buy
May 07Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings
Apr 21Organon Stock Is Still Worth A Look
Feb 24Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28
Feb 19Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last
Feb 16Organon: What I'm Looking For In This 8% Yield In 2024
Jan 03High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued
Dec 19Organon: It's Darkest Before The Dawn
Nov 30Organon: Poor Q3 Earnings Make Bear Case, But Dividend Is Saving Grace
Nov 07Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28
Nov 05Organon: The Federal Reserve Black Swan (Rating Upgrade)
Oct 046% Yield And Significantly Undervalued: A Closer Look At Organon
Sep 10Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk
Aug 10Organon & Co.: A Tough Spot To Be In Right Now
Jul 16Organon goes ex-dividend tomorrow
Feb 23Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Feb 19Is There Anything Organic Or Interesting About Organon?
Feb 07Organon goes ex-dividend tomorrow
Nov 09Organon's (NYSE:OGN) Dividend Will Be $0.28
Nov 08Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)
Nov 05Organon: Thoughts Ahead Of Q3 Earnings
Oct 31Organon: What Is The Recipe?
Aug 31Oragenics announces early toxicology data for intranasal COVID-19 vaccine
Aug 24Organon, Samsung Bioepis Humira biosimilar Hadlima high concentration dosage gets FDA nod
Aug 17Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28
Aug 07業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2026 | 6,509 | 1,080 | 1,110 | 1,138 | 6 |
| 12/31/2025 | 6,470 | 979 | 1,055 | 1,109 | 7 |
| 12/31/2024 | 6,393 | 758 | 658 | 1,162 | 7 |
| 6/30/2024 | 6,346 | 1,000 | 787 | 1,066 | N/A |
| 3/31/2024 | 6,347 | 1,047 | 458 | 761 | N/A |
| 12/31/2023 | 6,263 | 1,023 | 538 | 799 | N/A |
| 9/30/2023 | 6,150 | 585 | 424 | 669 | N/A |
| 6/30/2023 | 6,168 | 754 | 320 | 725 | N/A |
| 3/31/2023 | 6,145 | 746 | 431 | 849 | N/A |
| 12/31/2022 | 6,174 | 917 | 431 | 858 | N/A |
| 9/30/2022 | 6,292 | 1,011 | 138 | 638 | N/A |
| 6/30/2022 | 6,355 | 1,107 | 343 | 689 | N/A |
| 3/31/2022 | 6,365 | 1,304 | 564 | 1,077 | N/A |
| 12/31/2021 | 6,304 | 1,351 | 1,970 | 2,458 | N/A |
| 9/30/2021 | 6,314 | 1,525 | 2,370 | 2,841 | N/A |
| 6/30/2021 | 6,327 | 1,762 | 2,304 | 2,761 | N/A |
| 3/31/2021 | 6,258 | 1,917 | 2,772 | 3,025 | N/A |
| 12/31/2020 | 6,532 | 2,256 | 1,932 | 2,187 | N/A |
| 12/31/2019 | 7,777 | 3,306 | 2,675 | 2,767 | N/A |
| 12/31/2018 | 9,777 | 2,153 | 3,586 | 3,687 | N/A |
| 12/31/2017 | 10,500 | 1,801 | N/A | 3,419 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: OGNの予測収益成長率 (年間7.2% ) は 貯蓄率 ( 2.5% ) を上回っています。
収益対市場: OGNの収益 ( 7.2% ) US市場 ( 15.2% ) よりも低い成長が予測されています。
高成長収益: OGNの収益は増加すると予測されていますが、大幅には増加しません。
収益対市場: OGNの収益 ( 0.2% ) US市場 ( 8.8% ) よりも低い成長が予測されています。
高い収益成長: OGNの収益 ( 0.2% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: OGNの 自己資本利益率 は、3年後には非常に高くなると予測されています ( 97.7 %)。